Liver Disease Clinical Trials in New York

Showing 41-60 of 103 trials

Bridge to HOPE: Hypothermic Oxygenated Perfusion Versus Cold Storage Prior to Liver Transplantation

NCT05045794

This is a prospective, multi-center, controlled, randomized, pivotal study to evaluate the safety and effectiveness of the VitaSmart Liver Machine Perfusion System by comparing clinical outcomes in patients undergoing liver transplantation with ex-vivo liver preservation using static cold storage (SCS) followed by hypothermic oxygenated machine perfusion (HOPE) versus SCS only.

End Stage Liver DIseaseLiver Failure

Bridge to Life Ltd.219 participantsStarted Dec 2021

San Bernardino, California, United States • San Francisco, California, United States • Stanford, California, United States +13 more locations

COMPLETEDPhase 2< 1 mile

A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney Injury

NCT05309200

OCE-205 is being tested to treat participants who have developed Hepatorenal Syndrome-Acute Kidney Injury as a complication of cirrhosis with ascites. The study aims are to evaluate the safety and efficacy of OCE-205 at various doses. Participants will receive treatment by intravenous infusion. Participants will continue with this treatment until participants meets primary endpoint or any discontinuation criteria.

CirrhosisAscitesHepatorenal Syndrome+1 more

Ocelot Bio, Inc47 participantsStarted Apr 2022

Phoenix, Arizona, United States • Los Angeles, California, United States • San Francisco, California, United States +20 more locations

Bridge to HOPE: Hypothermic Oxygenated Perfusion Versus Cold Storage Prior to Liver Transplantation

A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney Injury

Liver Disease Trials in Other Cities

Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis

Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis

Integrated Stepped Care for Unhealthy Alcohol Use in HIV

A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis

A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis

Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis

The Effect of Transjugular Intraheptic Portosystemic Shunt (TIPS) on Gastrointestinal Motility and the Gut Microbiota

Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) Study

Losartan for the Treatment of Pediatric NAFLD

Diabetes Prevention Program for the Treatment of Nonalcoholic Fatty Liver Disease

Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children

Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis

Role of Probiotics in Treatment of Pediatric NAFLD Patients by Assessing With Fibroscan

Assessing Portal Hypertension With Methacetin Breath Test

Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis

Prediction Value of the BreathID 13C-Methacetin Breath Test for Hepatic Decompensation

Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC)

A Phase I Pharmacokinetic Study of TVB-2640 (Denifanstat) in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function

Other Conditions in New York